Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
9.39
-0.17 (-1.78%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $70.46 million as of April 1, 2025. Its market cap has increased by 1.82% in one year.
Market Cap
70.46M
Enterprise Value
-38.76M
1-Year Change
1.82%
Ranking
Category
Stock Price
$9.39
Market Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $70.46M, an increase of 75.27%. That is a compound annual growth rate of 4.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 79.70M | -20.54% |
Dec 31, 2024 | 100.30M | 86.09% |
Dec 29, 2023 | 53.90M | -14.98% |
Dec 30, 2022 | 63.40M | -43.14% |
Dec 31, 2021 | 111.50M | -44.19% |
Dec 31, 2020 | 199.80M | -62.51% |
Dec 31, 2019 | 532.90M | -7.48% |
Dec 31, 2018 | 576.00M | -26.83% |
Dec 29, 2017 | 787.20M | 276.11% |
Dec 30, 2016 | 209.30M | 61.75% |
Dec 31, 2015 | 129.40M | 54.60% |
Dec 31, 2014 | 83.70M | 5.02% |
Dec 31, 2013 | 79.70M | 185.66% |
Dec 31, 2012 | 27.90M | -71.93% |
Dec 30, 2011 | 99.40M | 135.55% |
Dec 31, 2010 | 42.20M | 4.98% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 727.14B |
UnitedHealth Group | 477.27B |
Johnson & Johnson | 398.95B |
AbbVie | 365.61B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 228.66B |
Merck & Co. | 224.93B |